H19 |
|
H19 imprinted maternally expressed transcript
|
|
|
0.494 |
0.923 |
ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
IH |
|
Hemihypertrophy
|
|
|
0.751 |
0.385 |
TLR2 |
O60603
|
toll like receptor 2
|
|
1.0E-06 |
0.361 |
0.923 |
BEST1 |
O76090
|
bestrophin 1
|
Ion channel
|
1.8E-12 |
0.465 |
0.885 |
EGFR |
P00533
|
epidermal growth factor receptor
|
Kinase
|
0.37 |
0.295 |
0.885 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
COL1A1 |
P02452
|
collagen type I alpha 1 chain
|
|
1.00 |
0.430 |
0.808 |
SPTA1 |
P02549
|
spectrin alpha, erythrocytic 1
|
|
2.6E-18 |
0.638 |
0.538 |
SLPI |
P03973
|
secretory leukocyte peptidase inhibitor
|
Enzyme modulator
|
9.0E-04 |
0.449 |
0.846 |
ALPL |
P05186
|
alkaline phosphatase, biomineralization associated
|
Enzyme
|
3.6E-04 |
0.546 |
0.769 |
ALPP |
P05187
|
alkaline phosphatase, placental
|
Enzyme
|
1.8E-13 |
0.487 |
0.808 |
COL1A2 |
P08123
|
collagen type I alpha 2 chain
|
|
1.00 |
0.486 |
0.846 |
EPB41 |
P11171
|
erythrocyte membrane protein band 4.1
|
|
3.6E-05 |
0.691 |
0.500 |
SPTB |
P11277
|
spectrin beta, erythrocytic
|
|
1.00 |
0.650 |
0.462 |
DMD |
P11532
|
dystrophin
|
|
1.00 |
0.423 |
0.923 |
PTHLH |
P12272
|
parathyroid hormone like hormone
|
|
0.81 |
0.453 |
0.846 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
ENPP1 |
P22413
|
ectonucleotide pyrophosphatase/phosphodiesterase 1
|
Enzyme
|
5.0E-08 |
0.498 |
0.808 |
APC |
P25054
|
APC regulator of WNT signaling pathway
|
|
1.00 |
0.373 |
0.962 |
MAPK3 |
P27361
|
mitogen-activated protein kinase 3
|
Kinase
|
3.7E-02 |
0.379 |
0.885 |
PRDX5 |
P30044
|
peroxiredoxin 5
|
|
1.8E-04 |
0.522 |
0.808 |
SCN4A |
P35499
|
sodium voltage-gated channel alpha subunit 4
|
Ion channel
|
1.3E-02 |
0.554 |
0.731 |
MLH1 |
P40692
|
mutL homolog 1
|
Nucleic acid binding
|
3.4E-05 |
0.399 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |